Ana Slaughter
Impact in
-
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 20
- Multiple Myeloma Research and Treatments 20
- Chronic Myeloid Leukemia Treatments 3
-
- Protein Degradation and Inhibitors 9
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Carolina Lonardi (13 shared papers)Hermann Einsele (9 shared papers)Jordan M. Schecter (9 shared papers)Philippe Moreau (8 shared papers)Kwee Yong (6 shared papers)Binod Dhakal (9 shared papers)María‐Victoria Mateos (4 shared papers)Nitin Patel (9 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (4 papers)Haematologica (2 papers)European Journal of Cancer (1 paper)Clinical Lymphoma Myeloma & Leukemia (9 papers)
- Partner nations
- GermanySpainUnited States
In The Last Decade
Ana Slaughter
17 papers receiving 63 citations
Peers
Comparison fields: 5 of 14
- Hematology 44
- Oncology 31
- Molecular Biology 24
- Radiology, Nuclear Medicine and Imaging 4
- Immunology 3
Countries citing papers authored by Ana Slaughter
This map shows the geographic impact of Ana Slaughter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Slaughter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Slaughter more than expected).
Fields of papers citing papers by Ana Slaughter
This network shows the impact of papers produced by Ana Slaughter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Slaughter. The network helps show where Ana Slaughter may publish in the future.
Co-authors
The 25 scholars most cited alongside Ana Slaughter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 23 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2014 | 4 | |
| 7 | 2015 | 3 | |
| 8 | 2016 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2022 | 2 | |
| 11 | OUTCOMES FOR OLDER PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE STRATUS (MM-010) TRIAL, A SINGLE-ARM, PHASE 3B STUDY | 2015 | 1 |
| 12 | THE STRATUS (MM-010) TRIAL: A SINGLE-ARM, PHASE 3B STUDY EVALUATING SAFETY AND EFFICACY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA | 2015 | 1 |
| 13 | 2014 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2015 | 1 | |
| 16 | 2014 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Ana Slaughter
Ana Slaughter is a scholar working on Hematology, Molecular Biology, Oncology, Pathology and Forensic Medicine and Immunology, having authored 22 papers that have together received 64 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (20 papers), Protein Degradation and Inhibitors (9 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers), CAR-T cell therapy research (3 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Mechanisms and Therapy (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Hematology (44 citations), Oncology (31 citations), Molecular Biology (24 citations), Radiology, Nuclear Medicine and Imaging (4 citations) and Immunology (3 citations). Ana Slaughter has collaborated with scholars based in Germany, Spain and United States. Frequent co-authors include Carolina Lonardi, Hermann Einsele, Jordan M. Schecter, Philippe Moreau, Kwee Yong, Binod Dhakal, María‐Victoria Mateos, Nitin Patel, Nikoletta Lendvai and Jesús F. San Miguel. Their work appears in journals such as Journal of Clinical Oncology, Blood, Haematologica, European Journal of Cancer and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.